Skip to main content
. 2001 Jan 30;98(3):1212–1217. doi: 10.1073/pnas.98.3.1212

Figure 6.

Figure 6

Intravenous coadministration of native IFN-α2 and FMS–IFN-α2 facilitates prolonged circulating antiviral activity from the time of administration. Groups of mice (n = 3 for each group) received intravenously native IFN-α2 (10 μg/mouse) or FMS7–IFN-α2 (10 μg/mouse) or both (10 μg of each). Blood aliquots were withdrawn at the indicated time points and analyzed in human WISH cells for antiviral activity.